Why Amazon Pharmacy Is Bad News for GoodRx Investors

Amazon's latest plan to deliver prescription medicines takes a swipe at GoodRx's popular discount card model.

File photo
File photo

Free discount coupons for prescription medicines allowed GoodRx (NASDAQ:GDRX) to make a name for itself and pull off a successful initial public offering in September. That success hasn't gone unnoticed by other companies that already have access to lots of consumers, including Amazon (NASDAQ:AMZN).

The recent introduction of Amazon Pharmacy includes a prescription savings benefit that gives all Prime members discounts on their medicines regardless of their health insurance coverage. Amazon even hired one of GoodRx's most important partners, Express Scripts, to manage the Prime members' new prescription savings benefit program.

A smiling pharmacist.

IMAGE SOURCE: GETTY IMAGES.

Amazon's latest step into the healthcare sector isn't necessarily disruptive, but it's going to put more pressure on GoodRx's struggling telehealth platform. Here's why.

Coming for the underinsured

Traditionally, healthcare plan sponsors hire pharmacy benefits managers (PBMs) to negotiate with drug manufacturers from a position of strength. The digital coupons that put GoodRx on the map route prescription drug sales through a PBM for people without insurance coverage.

Many of GoodRx's 4.9 million monthly active consumers have health plans, but end up paying less out of pocket for prescriptions that GoodRx runs through one of its PBM partners. The growth of GoodRx's customer base has been impressive, but pales in comparison to an estimated 126 million U.S.-based Amazon Prime members.